Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis

Background: Amyotrophic lateral sclerosis (ALS) is a devastating and untreatable motor neuron disease, with a 3–5-year survival from diagnosis. Possible prognostic serum biomarkers include albumin, C-reactive protein, ferritin, creatinine, uric acid, hemoglobin, potassium, sodium, calcium, glucose,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maurizio A. Leone, Jessica Mandrioli, Sergio Russo, Aliona Cucovici, Giulia Gianferrari, Vitalie Lisnic, Dafin Fior Muresanu, Francesco Giuliani, Massimiliano Copetti, The Pooled Resource Open-Access ALS Clinical Trials Consortium, Andrea Fontana
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-02-01
coleção:	Biomedicines
Assuntos:	amyotrophic lateral sclerosis neutrophil-to-lymphocyte ratio disease progression rate prognosis survival inflammation
Acesso em linha:	https://www.mdpi.com/2227-9059/10/2/354
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!